|
GMPS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.708600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.007000E-01 |
| Normal-vs-Stage2 |
5.487800E-01 |
| Normal-vs-Stage3 |
4.587900E-02 |
| Normal-vs-Stage4 |
7.519600E-01 |
| Stage1-vs-Stage2 |
4.281800E-01 |
| Stage1-vs-Stage3 |
8.777600E-03 |
| Stage1-vs-Stage4 |
5.928800E-01 |
| Stage2-vs-Stage3 |
2.384800E-01 |
| Stage2-vs-Stage4 |
9.685400E-01 |
| Stage3-vs-Stage4 |
3.645000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.058000E-01 |
| Normal-vs-AfricanAmerican |
4.871600E-01 |
| Normal-vs-Asian |
7.441800E-01 |
| Caucasian-vs-AfricanAmerican |
8.294200E-01 |
| Caucasian-vs-Asian |
8.856200E-01 |
| AfricanAmerican-vs-Asian |
9.424600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.232000E-01 |
| Normal-vs-Female |
5.6304000000007E-05 |
| Male-vs-Female |
1.94450000001734E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.460000E-01 |
| Normal-vs-Extreme_Weight |
3.773800E-01 |
| Normal-vs-Obese |
1.559410E-01 |
| Normal-vs-Extreme_Obese |
2.650200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.611200E-01 |
| Normal_Weight-vs-Obese |
4.305600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.761000E-01 |
| Extreme_Weight-vs-Obese |
5.139900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.944600E-01 |
| Obese-vs-Extreme_Obese |
1.267610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.842300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.353600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.281600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.570100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.345700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.476400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.050230E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.140600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.086300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.336840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.259200E-01 |
| Normal-VS-Type2 PRCC |
9.506200E-01 |
| Normal-VS-KIRP CIMP |
1.619050E-03 |
| Normal-VS-Unclassified PRCC |
2.170600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.098600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.59519999829183E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
8.182100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.91439999963627E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
2.565000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.986930E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.202560E-01 |
| Normal-vs-N1 |
4.437000E-03 |
| Normal-vs-N2 |
4.383200E-01 |
| N0-vs-N1 |
1.058670E-03 |
| N0-vs-N2 |
8.150100E-02 |
| N1-vs-N2 |
6.048600E-01 |
|
|
